<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">ACARBOSE <img border="0" src="../images/pr.gif"/></span><br/>(a-car'bose)<br/><span class="topboxtradename">Precose<br/></span><b>Classifications:</b> <span class="classification">hormone and synthetic substitutes</span>; <span class="classification">antidiabetic agent</span>; <span class="classification">alpha-glucosidase inhibitor</span><br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>50 mg, 100 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Acarbose is an oral alpha-glucosidase inhibitor. It inhibits or delays the absorption of sugars from the intestinal tract.
         The inhibitory effect of acarbose varies according to which enzymes are involved; from most to least inhibited are glucoamylase,
         sucrase, maltase, and isomaltase. Lactase is not affected by acarbose.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Acarbose reduces blood sugar by interfering with carbohydrate absorption from the GI tract.</p>
<h1><a name="uses">Uses</a></h1>
<p>As monotherapy or in combination with a sulfonylurea in patients with type 2 diabetes mellitus.</p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>In combination with insulin and metformin in patients with type 1 diabetes mellitus.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Inflammatory bowel disease, colon ulcers, partial bowel obstruction, predisposition for obstruction; patients 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>GI distress or liver disorders, pregnancy (category B).</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Diabetes Mellitus</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> Initiate with 25 mg q.d. to t.i.d. with meals, may increase q48wk up to 50100 mg t.i.d. with meals (max: 150 mg/d
               for <img src="../images/special/lesserorequal.gif"/>60 kg, 300 mg/d for &gt;60 kg)<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Remove drug from foil wrapper immediately before administration.</li>
<li>Give drug with first bite at each of the three main meals.</li>
<li>Do not store above 25° C (77° F). Keep tightly closed and protect from moisture.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> Sleepiness, weakness, dizziness, headache, vertigo (may be due to poor diabetic control). <span class="typehead">Endocrine:</span> Hypoglycemia (especially in combination with sulfonylureas and insulin). <span class="typehead">GI:</span>
<span class="speceff-common">Diarrhea, flatulence, abdominal distention,</span> borborygmi, increased liver function tests. <span class="typehead">Hematologic:</span> Anemia (especially iron deficiency). <span class="typehead">Skin:</span> Erythema, exanthema, urticaria. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<span class="classification"> sulfonylureas</span> may increase hypoglycemic effects. Drugs that induce hyperglycemia (e.g., <span class="classification">thiazides</span>, <span class="classification">corticosteroids</span>, <span class="classification">phenothiazines</span>, <span class="classification">estrogens</span>, <b>phenytoin,</b>
<b>isoniazid</b>) may decrease effectiveness of acarbose.  <span class="typehead">Herbal:</span>
<b>Garlic,</b>
<b>ginseng</b> may increase hypoglycemic effects. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Only 0.52% is absorbed intact from GI tract. After degradation by intestinal bacteria, up to 35% of dose may
      be absorbed. <span class="typehead">Peak:</span> Peak blood glucose reduction approximately 70 min after dose. <span class="typehead">Metabolism:</span> Metabolized in GI tract by intestinal bacteria and digestive enzymes. <span class="typehead">Elimination:</span> 35% excreted in urine, 51% excreted in feces, and 5% excreted in air as CO<sub>2</sub>. <span class="typehead">Half-Life:</span> 2 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Lab tests: Periodically monitor blood glucose, HbA<sub>1C</sub> liver, enzymes, Hct and Hgb.
         </li>
<li>Treat hypoglycemia with dextrose; not with sucrose (table sugar).</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>
            							Note: Acarbose prevents the breakdown of table sugar. Have a source of dextrose, such as dextrose paste, available to treat low
            blood sugar.
            						
         </li>
<li>Monitor closely blood glucose especially following dosage changes.</li>
<li>Report abdominal distress; dietary adjustment or dosage reduction may be warranted.</li>
<li>Monitor weight and report significant changes.</li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>